PMV Pharmaceuticals, Inc

PMVPNASDAQ • USD
1.20 USD
↗ 0.01 (1.18%)🟢LIVE (AS OF 02:25 PM EST)
🟢Market: OPEN

PMVP is currently priced at $1.20. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 16, 2026.

Open?$1.22
High?$1.30
Low?$1.08
Prev. Close?$1.19
Volume?646.3K
Avg. Volume?431.3K
VWAP?$1.15
Rel. Volume?1.50x
Bid / Ask
Bid?$1.19 × 400
Ask?$1.20 × 100
Spread?$0.01
Midpoint?$1.19
Valuation & Ratios
Market Cap?89.9M
Shares Out?75.5M
Float?38.3M
Float %?71.8%
P/E Ratio?N/A
P/B Ratio?1.57
EPS?-$1.17
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
Employees
54
Market Cap
95.9M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-09-25
Address
400 ALEXANDER PARK DRIVE
PRINCETON, NJ 08540
Phone: (609) 642-6670
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
54
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.78Distress
Confidence?53%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?5.62%Elevated
Short Interest?2.2M
Days to Cover?5.6
Free Float38.3M
Avg Daily Volume383.3K
Settlement Date2026-10-30
Financial Health
Current Ratio?9.81Strong
Quick Ratio?9.81Strong
Cash Ratio?1.87Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
85
1.57CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.9CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-155.0%WEAK▾
ROA?
S&P
3
-79.5%WEAK▾
Cash Flow & Enterprise
FCF?$-69644000
Enterprise Value?$69.9M
Fundamentals ratios updated end of day